Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety epidemiological study of Daikenchuto (TJ-100) and risk of liver injury after colectomy or gastrectomy in cancer patients
jRCT1031240102Completed
- Sponsor
- Tsumura & Co.
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of daikenchuto in colon cancer and gastric cancer (GC) (2 arms), sponsored by Tsumura & Co. Started May 2024; status: completed.
02
Drugs
daikenchuto
03
Conditions
colon cancergastric cancer (GC)
Beyond the preview
Go deeper on jRCT1031240102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031240102.